A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen

@article{Culine2006API,
  title={A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen},
  author={St{\'e}phane Culine and Christine A Theodore and Maria de Santis and Binh Nguyen Bui and Tomasz Demkow and Jerzy Lorenz and Fr{\'e}d{\'e}ric Rolland and F Delgado and Blandine Longerey and Nicholas James},
  journal={British Journal of Cancer},
  year={2006},
  volume={94},
  pages={1395 - 1401}
}
A multicentre phase II trial to determine the efficacy of vinflunine as second-line therapy in patients with advanced transitional cell carcinoma (TCC) of the bladder; secondary objectives were to assess duration of response, progression-free survival (PFS) and overall survival (OS), and to evaluate the toxicity associated with this treatment. Patients had tumours that failed or progressed after first-line platinum-containing regimens for advanced or metastatic disease, or had progressive… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 37 references

A single arm, multicenter, open label, phase II study of lapatinib as 2L treatment of pts with locally advanced/metastatic transitional cell carcinoma of the urothelial tract

  • C Wulfing, J Machiels, +8 authors I El-Hariry
  • Proc Am Soc Clin Oncol 23(16S): 401s,
  • 2005

Phase 2 study of bortezomib in advanced urothelial cancer. A trial of the Princess Margaret Hospital (PMH) Phase II Consortium

  • SS Sridhar, W Stadler, +6 authors M Moore
  • Proc Am Soc Clin Oncol 23(16S): 422s,
  • 2005

The impact of renal impairment on eligibility for adjuvant cisplatin-based chemother

  • A Dash, T Koppie, K Vora, B Bochner, MD Galski
  • 2005
1 Excerpt

Similar Papers

Loading similar papers…